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Abstract: With the increasing size of the elderly population and evolving imaging technology, 
silent brain infarction (SBI) has garnered attention from both the public and the physicians. 
Over 20% of the elderly exhibit SBI, and the prevalence of SBI increases steadily with age, ie, 
30%–40% in those older than 70 years. Well-known cardiovascular risk factors such as hyper-
tension has been identified as a risk factor of SBI (odds ratio [OR] = 3.47) Besides this, blood 
pressure (BP) reactivity to mental stress, morning BP surges, and orthostatic BP changes have 
been demonstrated to contribute to the presence of SBI. Further, a metabolic syndrome not only 
as a whole syndrome (OR = 2.18) but also as individual components could have an influence on 
SBI. Increased C-reactive protein and interleukin-6, coronary artery disease, body mass index, 
and alcohol consumption have also been associated with SBI. The ORs and   possible mecha-
nisms have been discussed in this article. Overt stroke, dementia, depression, and aspiration 
pneumonia were all associated with SBI. (overt stroke: hazard ratio [HR] = 1.9, 95% confidence 
interval [CI]: 1.2–2.8; dementia: HR = 2.26, 95% CI: 1.09–4.70). We also looked into their close 
relationship with SBI in this review.
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Introduction
Silent stroke, and in particular, silent brain infarction (SBI), is a term owing to recent 
developments in cerebral imaging. As more healthy people undergo routine screening 
imaging as part of health evaluations, more SBIs are being detected in people of all ages. 
Because of the significance of stroke as the leading cause of disability and mortality, 
SBI has garnered a lot of attention from both the public and the clinicians.
With increasing life expectancy, elderly people can expect to survive several years 
or even decades longer than previously. Therefore, SBI is becoming a main concern for 
them. How often is SBI detected in the elderly? What are the age-specific incidences? 
Which risk factors contribute to the presence of SBI? Does SBI really lead to more 
serious health problems such as stroke? These are the kind of questions that are still 
unanswered and for which several researchers have been diligently trying to resolve.1
In this article, the current knowledge of SBI has been discussed including the 
working definition, as well as its epidemiology, risk factors, and health consequences, 
particularly in the elderly.
Methods
We did a literature search in PubMed using the terms silent brain infarction, silent 
cerebral infarction, silent lacunar infarction, and asymptomatic cerebral infarction. Clinical Interventions in Aging 2010:5 submit your manuscript | www.dovepress.com
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Those studies that involved subjects older than 60 years of 
age were included. For the others, we reviewed and   referenced 
these for the sake of comparison. Referenced articles were 
limited to the full-text papers published in English over an 
unlimited period of time.
Criteria for SBI
The definition of SBI was inconsistent throughout the articles. 
SBI was usually defined as focal T2 hyperintensities .3 mm 
with correlative T1 hypointensities.1,2 However, there were 
several discrepancies about the size and the presence of 
correlative T1 hypointensities.3 Also, in some studies, 
authors divided the lesions into 3 groups: SBI (focal T2 
hyperintensities .3 mm with correlative T1 hypointensity), 
focal white matter T2 hyperintensity lesions (FWT2HLs) 
similar to SBI but without correlative T1 hypointensity, and 
periventricular hyperintensity (PVH) using magnetic reso-
nance imaging (MRI).2
Further, clinicians sometimes misinterpreted the 
  Virchow-Robin spaces as SBI. In one study by a Japanese 
study group,3 discriminating characteristics were described 
using MRI. Authors pointed that SBI was different from Vir-
chow-Robin spaces in locations, shapes, and sizes. Among 
them, the size was the most important   discriminating factor. 
For the most part, Virchow-Robin spaces were ,2 × 1 mm. 
Further, SBI was wedge-shaped, whereas the Virchow-Robin 
spaces were round or linear. The locations of the lesions 
also should be considered in the differentiation. If lesions 
were located in the brainstem, SBI was more probable than 
Virchow-Robin spaces. In basal ganglia, other than in the 
lower part, SBI was more probable than Virchow-Robin 
space in lesions .3 × 2 mm. In the lower part of basal gan-
glia, the discrimination was not easy, so the proton density 
image, shape of the lesion, and symmetry of their distribution 
should be considered prior to the decision.3,4 If the lesions 
were located in the subcortical area and hypointense on 
T1 images, those lesions should be classified as SBI.5
In summary, SBI can be defined as focal T2 hyperintense 
lesions .3 mm, which are mostly hypointense on T1 images.5 
Their size, shape, and locations are all needed to differentiate 
them from other anatomical structures such as Virchow-
Robin spaces (Figure 1).
Epidemiology of SBI – incidence
The incidence of SBI could be assumed by the Rotterdam 
Scan Study.6 Of 1,077 participants aged 60–90 years, 
668 subjects were followed up for 3.4 years on average 
by MRI. Ninety-three subjects (14%) showed one or more 
newly-detected lesions in the second MRI. Among them, 81 
(12%) had SBI, and the remaining had symptomatic lesions. 
Those who had SBI on baseline MRI tended to have new 
lesions on follow-up (age-adjusted and sex-adjusted odds 
ratio [OR] = 2.9; 95% confidence interval [CI]: 1.7–5.0). The 
cumulative incidence over 3.4 years was increased according 
to age resulting in 8% in subjects of 60 and 70 years and 22% 
in subjects older than 80 years.
A cardiovascular health study was conducted in 1,433 
participants who were older than 65 years.7 They were fol-
lowed up for 5 years and underwent MRI scans. A total of 225 
subjects (15.7%) showed new infarctions on MRI without 
definite focal neurologic deficits. The authors classified them 
as covert infarcts rather than silent because they showed 
decreased scores on the modified minimental state examina-
tion and digit symbol substitution test (both P , 0.01).
Epidemiology of SBI – prevalence
In the Rotterdam Scan Study, 259 subjects (24%) among 
1,077 participants showed one or more infarct lesions at 
baseline.8 Further, 217 (20%) had silent lesions, 26 (2.4%) 
symptomatic, and 16 (1.5%) had both. The prevalence 
increased with ages. In the 60-year-old to 64-year-old group, 
the prevalence was 8%, whereas it was up to 35% in the 
85-year-old to 90-year-old group. SBI was more common in 
the female group (age-adjusted OR = 1.4; 95% CI: 1.0–1.8). 
In a study of 153 community-dwelling elderly, older than 
66 years, which looked at their plasma homocysteine (pHcy) 
levels and methylenetetrahydrofolate reductase (MTHFR) 
gene, SBI was detected in 24.8% of subjects.9 Autopsies 
were conducted in a Japanese community-based study.10 
In 26 years, from 1961 to 1987, 966 subjects in Kyushu, 
Hisayama, were enrolled into this study. Subjects who were 
older than 40 years were included, and the mean age at 
autopsy was 78 years (range, 42–97 years; mean ± standard 
deviation [SD], 78.3 ± 9.5 years). SBI was detected in 12.9% 
of patients.11
For comparison, only 88 (5.5%) subjects showed SBI 
among 1,588 neurologically healthy adults (927 males and 
661 females; mean age 53.6 years) who underwent brain 
MRIs at a university hospital healthcare center.12 Another 
study revealed similar prevalence resulting in an age-adjusted 
SBI prevalence of 5.1% among 994 healthy adults (mean 
age 49.0 ± 7.7).13
There were considerable discrepancies in the prevalence 
rates listed in these studies due to differences in age distribu-
tion and the presence of underlying cardiovascular diseases 
in the study population (Table 1). However, it was evident Clinical Interventions in Aging 2010:5 submit your manuscript | www.dovepress.com
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that the prevalence showed increments between the ages 60 
and 80 years.
Epidemiology of SBI in patients 
with comorbidity
The prevalence of SBI in the patients with various diseases 
also should be considered. In the community-based study, the 
presence of chronic kidney disease (CKD) and SBI showed sig-
nificant associations in the elderly (OR = 1.86).14 In the patients 
with CKD, the prevalence of SBI was 56.5%, and it showed a 
significant inverse correlation with the estimated glomerular 
filtration rate.15 In another study, 25% of patients with a creati-
nine clearance (CCr) . 40 mL/min/1.73 m2 showed SBI, 85% 
with a CCr , 40 mL/min/1.73 m2, and 29% with control with 
AB
CD
Figure 1 Magnetic resonance imaging from patients with silent brain infarctions and virchow-Robin spaces: (A) several silent brain infarctions (arrow) in the axial image of 
the FLAIR sequence; (B–D) numerous virchow-Robin spaces in the basal ganglia (circle) in the FLAIR axial, T2-weighted axial, and T1-weighted saggital images.Clinical Interventions in Aging 2010:5 submit your manuscript | www.dovepress.com
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Table 1 Prevalence of SBI
Study Population/subjects  Mean age, y  
(range)
N Prevalence, % Reference
Total Age, y
60s 70s 80s
Rotterdam scan study Community-dwelling,  
nondemented elderly people 
76 ± 7 (60–90) 1,077 20 8 35 8
Matsui et al (Japan) Community-dwelling,  
nondemented elderly  
older than 66 y
76.7 ± 5.3 (66–88) 153 24.8 9
Hisayama study  
(Kyushu, Japan)
Community-based  
autopsy study
78.3 ± 9.5 (42–97) 966 12.6 10
Kwon et al  
(Seoul, Korea)
Healthy subjects for routine  
health check, no history  
of stroke or TIA
69.8 (65–96) 1,254 15.7 11.7 18.0 27.6 (.75) 40
SMART study Patients with vascular disease  
except stroke and transient  
ischemic attack
58 (18–79) 308 17 11
Kwon et al 
(Seoul, Korea)
Neurologically healthy  
adults at university hospital  
healthcare center
53.6 (20–86) 1,588 5.5 9.4 17.5 (.70) 12
Lee et al (Seoul, Korea) Normal healthy adults 49.0 ± 7.7 (20–78) 994 5.1 19.8 43.8 13
Abbreviations: SBI, silent brain infarction; TIA, transient ischemic attack.
essential hypertension (HTN) and normal renal function.16 For 
the patients who underwent hemodialysis, the prevalence of 
SBI was higher than those of general population (48.8% vs 
9.6%, P , 0.0001; mean age 55.6 ± 12.3; n = 175).17
As for the mechanism, it was suggested that brain and 
kidney had similar anatomical and physiological vascular 
beds, and this could be the reason for SBI.15 HTN,   especially 
systolic blood pressure (BP), was strongly correlated with the 
prevalence of SBI in the patients with CKD. High blood flow 
is constantly perfused through the low-resistance vascular 
beds throughout systole and diastole. The authors suggested 
that the hemodynamic stress to these vascular beds could 
result in small-vessel injuries to both brain and kidney.15
Migraine was also associated with SBI. Among the 
patients with migraine with aura (MA), 8.1% of 161 subjects 
showed silent lesions. The prevalence of SBI was 2.2% in the 
subjects with migraine without aura, and 0.7% in the control 
subjects (age distribution, 20–60 years).18
Carotid artery stenosis was also identified as a predictor 
of SBI, especially located in basal ganglia (OR = 3.246; 
95% CI: 1.116–9.444; P = 0.0307; mean age with SD, 
63.2 ± 9.5 years).19 Approximately 23% of the patients 
with asymptomatic carotid stenosis showed SBI (mean 
age, 68 years).20 The incidences of SBI in the patients with 
carotid stenosis was approximately 23% (range, 0%–50%), 
which were identified on the diffusion-weighted MRI, whom 
  underwent carotid endarterectomy or carotid artery stenting.1 
They were mostly reversible on the follow-up imaging. In 
their results, the incidence was higher in the carotid stenting 
than endarterectomy (29% vs 10%).
Distribution of SBI
The distribution of SBI has been studied in adult subjects, 
however, not in the elderly. The basal ganglia have been 
the most prevalent location, followed by subcortical white 
matter, thalamus, cerebral cortex, and infratentorial regions 
such as cerebellum and brainstem (Figure 2).6,8,13,21–23
Pathophysiology of SBI
There have been scant reports regarding the pathophysiology 
of SBI. Small vessel disease and cardiogenic or arteriogenic 
emboli have all been suggested as possible pathophysiologic 
mechanisms of SBI.
“Small vessel disease” through the occlusion of small, 
deep, perforating arteries was suggested as a causative 
mechanism of lacunar infarctions. Its concept and detailed 
pathologic characteristics were described by Fisher in the 
postmortem study.24 In his article, he showed that most 
asymptomatic lacunar infarctions were caused by the occlu-
sion of arteries approximately 40–200 µm in diameter. Many 
large arteries that were approximately 200–800 µm in diam-
eter could cause the symptomatic ones. Small vessel lesions 
were characterized by fibrinoid necrosis, loss of normal wall 
architecture, and mural foam cells.
The majority of SBI is lacunar infarction,8 and the absence 
of lesion-corresponding steno-occlusive changes in major Clinical Interventions in Aging 2010:5 submit your manuscript | www.dovepress.com
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vessels and the usual locations of SBI are all the supporting 
evidences of small vessel disease as a main pathophysiology 
of SBI.21
However, there are conflicting data against this theory. 
In a recent article with CADASIL (cerebral autosomal 
dominant arteriopathy with subcortical infarcts and 
leukoencephalopathy) patients, it has been shown that the 
lacunar infarctions of leuticular nucleus were caused by 
hemodynamic change related with impaired cerebral auto-
regulation, not by small vessel occlusion.25
The white matter lesions (WML) also could shed light on 
the pathophysiology of SBI. It had the significant association 
with lacunar infartions.26 In the Rotterdam Scan Study, the 
periventricular and subcortical WML in upper tertiles was 
associated with higher risk of stroke than those in the low-
est tertile (hazard ratio [HR] = 4.7; 95% CI: 2.0–11.2 and 
HR = 3.6; 95% CI: 1.4–9.2, respectively). This association 
is more stronger in the periventricular WML than those of 
subcortical ones.27 Periventricular WML was suggested to 
have somewhat different pathophysiology with a subcorti-
cal one.28 It was suggested that traumatic damage to the 
loosely arranged network around the ventricle could be 
caused by increased intracranial pulse pressure based on 
the alterations in the signal of the ependymal wall through 
the detailed   three-dimensional MR analysis. The lesions also 
could not show spatial relationship with perforant arteries. 
  Furthermore, the significant arteriolar luminal stenosis or 
occlusion was not detected in the patients with WML.29
In the patients with migraine, the lesions were all located 
in the junctional regions of the cerebellum.30,31 The authors 
suggested that the combination of migraine attack–related 
hypoperfusion and embolism could be explanations for 
it rather than small vessel disease or atherosclerosis. The 
cerebral blood flow reduction that was up to 7%–50% could 
be accompanied during the cortical spreading depression 
in MA. The terminal arteries in cerebellum, which did not 
have good anastomoses, became narrow in diameter as they 
enter into the terminal portions in the parenchyma. Superior 
cerebellar artery is longer than antertior inferior cerebellar 
artery or posterior inferior cerebellar artery; thus in the 
case of blood flow reduction, thrombi could be produced 
  easily. Microemboli also could not be washed out and make 
an occlusion eventually. Besides these, there could be an 
increment of blood–brain permeability, coagulopathy, and 
secretion of vasoactive peptides. All these changes could 
contribute to the occurrence of junctional lesions. In the other 
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Figure 2 Distribution of SBI. 
Note: Distribution of the silent brain infarctions is described in the diagram. The number of vertical lines denotes the frequencies (percent) of corresponding lesions. 
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aspect, the pronounced, prolonged, diffuse   hyperperfusion 
in the migraine patients also could cause rheological 
  barotraumas and   pressure diapedesis to the deeper arterioles, 
and thus eventually cause arterial wall degeneration through 
  lipohyalinosis and fibrinoid necrosis.32
Up to now, small vessel occlusion might have been 
suggested as an important explanation for SBI. However, 
there were several conflicting data about its role as main 
pathophysiologic mechanism. There were good reasons 
supporting that hemodynamic and embolic events also need 
to be considered.
Risk factors
Hypertension
HTN has been a consistent major risk factor of SBI in   various 
studies. The Rotterdam Scan Study revealed a significant rela-
tionship between HTN and SBI after adjusting for age and sex 
(OR = 2.4; 95% CI: 1.7–3.3).8 Other studies reproduced these 
results in 175 neurologically healthy elderly who were older 
than 65 years (OR = 3.54; 95% CI: 1.47–8.59)33 and in 994 
normal healthy adults (OR = 3.47; 95% CI: 1.71–7.03).13
Another interesting factor was systolic and diastolic BP 
reactivity related with mental stress. In a previous study that 
enrolled 67 healthy elderly aged between 55 and 81 years, the 
relationship between the BP reactivity and SBI was evaluated. 
The systolic and diastolic BP responses to 3 laboratory-based 
mental stressor were recorded. In their results, those BP reac-
tivities were signficantly related with SBI even after adjusting 
for the resting BP (systolic BP: r2 = 0.14, P = 0.004; diastolic 
BP: r2 = 0.08, P = 0.04). Authors have assumed that the BP 
response to the various mental stressors was the risk factor of 
SBI.34 Several mechanisms were proposed. Exaggerating BP 
response was suggested to be a sign of dysregulated autonomic 
function and thus could be associated with recurrent transient 
cerebral hypoperfusion. Furthermore, impaired vasomotor 
reactivity, impaired autoregulation, and following transient 
vasospasm could represent causes of the silent lesions.
Morning BP surges have also garnered a lot of attention. 
This was defined as a subtraction from the mean systolic BP 
during the 2 hours after awakening with mean systolic BP 
during the 1 hour that included the lowest sleep BP (n = 191, 
elderly hypertensive, average age 76 ± 6.9).35 In this study, 
they divided the subjects into 2 groups with a cutoff value 
of 55 mmHg and compared the incidence of SBI and overt 
stroke between the 2 groups. According to their results, the 
morning surge (MS) group showed a higher prevalence 
of SBI than the non-MS group after matching for age and 
24-hour ambulatory BP (70% vs 49%, P , 0.01).
A total of 224 elderly hypertensive subjects older than 
60 years were enrolled in another study.36 Orthostatic HTN, 
defined as an increase of over 20 mmHg after standing, 
revealed a significantly higher prevalence and number of SBI 
lesions per person compared with the normal group (81% vs 
48%; 3.4 per person vs 1.4 per person, P , 0.0001). However, 
they also showed higher morning BP (159 vs 149 mmHg, 
P = 0.007) and a higher BP variability (standard deviation 
of awake SBP) than the normal group (21 vs 17 mmHg, 
P , 0.0001). Orthostatic hypotension, which was defined as a 
decrease of over 20 mmHg also indicated a higher number of 
SBI lesions per person (2.7 vs 1.4 per person) after an adjust-
ment for confounding factors.36 Postprandial hypotension, 
extreme dipping, and increased ambulatory BP variability 
have been suggested to be associated with SBI.37
As for the mechanism, impaired cerebral autoregulation 
and reduced cardiovascular reserve capacity were proposed.36 
In the above results, the orthostatic HTN group was older 
and showed a significantly higher number of left ventricular 
hypertrophy on electrocardiogram. This might suggest that 
their longer and more severe history of HTN could have an 
effect on the prevalence of SBI.
Moreover, ischemic brain lesions could result in the 
impairment of autonomic nervous system by itself.38 The 
parasympathetic nervous system, which could be evaluated 
by high-frequency power spectrum (HF), was decreased 
after acute cerebral infarction. The authors reported that 
the lacunar infarctions of the putamen or thalamus were 
associated with these changes. So they suggested  that 
SBI of these locations could contribute to the autonomic 
dysfunction and also could be an explanation for the unstable 
BP profiles.
Metabolic syndrome
Metabolic syndrome consists of high BP, impaired   fasting 
glucose (IFG), high triglyceride (TG) levels,   abnormal high-
density lipoprotein (HDL) levels, and increased abdominal 
circumference (AC).39 It has gathered attention because 
several studies have shown its contribution to major car-
diovascular diseases, acting as a major risk factor. A recent 
study showed its significant relationship with SBI in 1,254 
subjects who were older than 65 years (OR = 1.68; 95% CI: 
1.15–2.44).40 These tendencies were confirmed in middle-aged 
subjects (adjusted OR [AOR] = 6.52; 95% CI: 4.30–9.90) and 
in normal healthy adults (mean age 53.6 years, ranged from 
20 to 86 years; OR = 2.18; 95% CI: 1.38–3.44).12,41
Both the full syndrome ($3 of the 5 components) and 
each of the components were correlated with SBI. It was Clinical Interventions in Aging 2010:5 submit your manuscript | www.dovepress.com
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likely that those who have a higher number of components of 
a metabolic syndrome exhibited more numerous SBI lesions. 
Among these components, the high BP revealed the strongest 
correlation with SBI (OR = 1.89; 95% CI: 1.23–2.91),40 and 
the OR of elevated BP was as high as 4.51 compared with 
1.25 of low HDL or 1.28 of high TG.12 Though only BP and 
fasting blood glucose level are usually taken into consider-
ation, TG and AC also need to be considered and should be 
managed properly to prevent the SBI.
Metabolic syndromes can affect the brain in various ways. 
For example, some studies have shown the   inflammatory 
activity, increased action of free radicals, changes of neu-
rotrophic factors, and reduction of insulin transport into the 
brain in the patients with metabolic syndrome.42,43 It has also 
been identified as a heterogenous complex that could contrib-
ute to both atherothrombotic and lacunar   infarctions.44 Various 
components such as HTN, abnormal TG, and   obesity could 
affect the vascular endothelium and thus cause ischemia.
elevated C-reactive protein
C-reactive protein (CRP) is an important inflammatory 
marker and closely related with the occurrence of the cardio-
vascular diseases. In the Rotterdam Scan Study, 636 elderly 
aged 60–90 years were followed up for 3.3 years, and it was 
found that high CRP attributed to the high prevalence and 
incidence of the incident lacunar infarction although this 
association was not significant.45 Another study, which was 
conducted prospectively in 194 neurologically healthy sub-
jects (mean age 67.3 ± 7.5), showed that the mean CRP and 
interleukin-6 (IL-6) levels of the SBI(+) group was higher 
than the SBI(−) group.21 The prevalence of SBI increased 
as the level of the inflammatory markers increased (CRP: 
OR = 1.85/SD increase; IL-6: OR = 2.00/SD increase).
As for the mechanism, inflammatory endothelial activa-
tion and dysfunction were observed in the patients with small 
vessel disease.45–47 Chronic inflammation process in the cere-
bral small vessels was suggested to cause the microangiopa-
thy and eventually ischemia. Further, CRP can be elevated 
as a response to ischemic tissue damage.21
There was another insightful theory regarding the role of 
CRP in lacunar infarctions and WMLs.45 Despite the absence 
of inflammatory cells in the vessel walls, endothelial inflam-
mation markers such as intercellular adhesion molecules and 
vascular cell adhesion molecules increased in the lacunar 
infarctions and WMLs. This suggested that inflammatory 
endothelial activation had a role in SBI by itself. Neuron and 
glia also could be more vulnerable to cerebral hypoperfusion 
due to inflammation through microglial activation.48
Hyperhomocysteinemia
The total pHcy has been suggested as a potential modifiable 
risk factor of cerebral atherosclerosis, stroke, and dementia.49 
The arterial wall can be affected and the vascular damage 
may happen due to hyperhomocysteinemia.
In one particular study, 153 community-dwelling elderly 
people aged older than 66 years were enrolled, and their pHcy 
level and MTHFR gene were measured.9 They found that SBI 
was in 24.8% of subjects. The pHcy level was higher in the 
SBI(+) group than in the SBI(−) group (13.6 ± 4.1 mmol/L vs 
11.0 ± 3.3 mmol/L, P = 0.0004).
The previous results were reproduced in another 
study of 161 patients with SBI and 126 healthy sub-
jects (mean age ± SD; 63.02 ± 11.26 and 61.98 ± 10.14, 
respectively).50 When the total pHcy level was stratified as 
high ($11.77 µmol/L), moderate (8.71–11.76 µmol/L), and 
low (#8.70 µmol/L), the AOR of the high-level pHcy group 
for SBI (AOR = 4.78, 95% CI: 2.45–9.33) was significantly 
greater than that of the low group (AOR = 1.00). Besides 
these, the MTHFR 677TT genotype among the various 
polymorphisms in the SBI patients showed a significant cor-
relation with increased pHcy level. That group also revealed 
an inverse correlation between pHcy and folate level. This 
suggested that folate supplementation in this specific genetic 
group could reduce the frequency of SBI.
Another cross-sectional study was conducted in the 
  Rotterdam Scan Study for elderly participants aged 
60–90 years.49 Mean total pHcy level was 11.5 µmol/L 
(SD = 4.1), and the occurrence of SBI increased with higher 
total pHcy level after adjustment for cardiovascular risk 
factors (OR = 1.24/SD increase; 95% CI: 1.06–1.45). These 
data suggested that the pHcy level could contribute to the 
  subsequent occurrence of SBI.
As for the mechanism, hyperhomocysteinemia could cause 
the endothelial cell injury, increased platelet aggregation, 
and abnormalities of the fibrinolysis.51 Increased synthesis 
of thromboxane A2 and decreased synthesis of prostacyclin 
could cause the increased platelet aggregation. It also could 
contribute to impaired endothelium-dependent vasodilatation 
and enhanced lipoprotein(a) binding to fibrin. All these com-
ponents together might be the causes of increased frequency 
of SBI in the patients with hyperhomocysteinemia.
Coronary artery disease
Coronary artery disease (CAD) was analyzed for its 
  correlation with SBI in one study that enrolled 133 CAD 
patients who underwent coronary angiography (mean age, 
65.3 years).52 When the patients were stratified into 3 groups Clinical Interventions in Aging 2010:5 submit your manuscript | www.dovepress.com
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according to the number of steno-occlusive coronary   vessels, 
the   prevalence of SBI was significantly different between 
each groups (zero-vessel, 27.3%; one-vessel, 55.6%; 
  two-vessel, 81.3%; three-vessel, 74.2%; P = 0.0002). Further, 
the maximal size and multiplicity of SBI in the two-vessel 
(1.00 and 1.44) and three-vessel (0.94 and 1.26) groups were 
significantly higher than those of the zero-vessel (0.27 and 
0.50) CAD group (P = 0.0002, P = 0.0025, respectively).
In another study, they used a different approach to reveal 
the difference in the characteristics and progression of SBI 
between the HTN and CAD patients.53 They studied the 
location and multiplicity of the SBI in 107 CAD patients 
who were diagnosed by coronary angiography (mean age, 
62 years) and 101 HTN patients who were negative for 
the history of stroke (mean age, 60 years). The number of 
multiple SBI carriers who had 3 or more SBI lesions was 
significantly higher in the CAD plus HTN group than in the 
HTN-only group (46% vs 21%, P = 0.001). According to 
multiple logistic regression analysis, the number of involved 
coronary vessels in CAD patients and the age of the HTN 
patients were proven as independent determinants of SBI 
(OR = 2.28, 95% CI: 1.39–3.76, P , 0.005; OR = 1.09, 
95% CI: 1.04–1.15, P , 0.001, respectively). In patients 
with CAD, the SBI of deep perforator territory, such as 
basal ganglia and thalamus, was significantly associated 
with the involved vessel number (P , 0.005). According to 
their results, the progression of SBI was more severe in the 
multivessel CAD and HTN(+) CAD groups than the HTN-
only and HTN(−) CAD groups. The severity of the coronary 
atherosclerosis was also more closely correlated with the SBI 
of deep perforator territory than that of white matter. In sum-
mary, the presence and severity of CAD contributed to the 
pathologic process of SBI independent of HTN.
With respect to the mechanism, the authors proposed that 
the risk factors shared by both the coronary heart disease and 
the ischemic infarcts could be the explanation for their obser-
vations.53 It was suggested that risk factors such as HTN and 
old age may cause systemic atherosclerosis and thus result 
in both CAD and SBI. Microthromboembolism caused by 
ventricular dysfunction, complicated atrial fibrillation (AF), 
and carotid artery or aortic arch stenosis was also suggested 
as a possible pathogenic mechanism of SBI.
Atrial fibrillation
There have been interesting theories regarding the patho-
genesis of SBI in patients with AF.54 Japanese researchers 
  compared the incidence of SBI between AF and control 
groups and found a significant increase in the incidence 
of SBI in AF patients. Although major cardiovascular risk 
factors such as HTN and diabetes were more prevalent 
in AF subjects, the authors focused their attention on the 
decreased incidence of SBI during a follow-up period after 
aspirin prescription. Unlike the typical embolic lesions, these 
were located mainly in the deep perforated sites, and aspirin 
was able to attenuate the number of lesions. Therefore, the 
authors assumed their SBI lesions could have resulted from 
microthrombi, not from embolic events.
In another study, the authors showed that nitric oxide (NO) 
synthesis could be attenuated by irregular heart rate in AF 
patients.55,56 Vascular endothelium has also been   suggested to 
show sclerotic changes caused by irregular shear stress.57,58 
Along with this, P-selectin expression on platelets increased. 
All these changes could contribute to the increased risk of 
ischemic lesions.
Genetic risk factors
Besides MTHFR protein described above, there were several 
genetic risk factors for SBI.
Susceptibilities to SBI and white matter hyperintensities 
by genetic polymorphisms were studied by several groups. 
Several genes such as protein kinase C η (PRKCH) gene, 
angiotensin-converting enzyme (ACE), and apolipoprotein 
(a) [apo(a)] were proposed as possible candidates, though 
results were not consistent throughout the studies.59
High concentration of lipoprotein(a) [Lp(a)] can cause 
dyslipidemic condition and thus finally atherothrombosis.59 
Furthermore, apo(a) itself might have an effect on the   vascular 
endothelial cell, smooth muscle cell, and   monocytes through 
lipohyalinotic or fibrinoid necrotic change, and finally cause 
the disintegrity of small arterial wall.59 Apo(a) size polymor-
phism did not change easily like Lp(a) concentration by a 
number of environmental factors, such as sex hormone and 
acute inflammation. In one study, high frequency of apo(a) 
allele V that was designated for the combination of alleles 
I–IV was significantly associated with SBI and symptomatic 
subcortical infarction; however, it was evident only in the 
young subjects.59 ACE D/I polymorphism was also suggested 
as a risk factor of SBI in the several previous reports though 
the results were conflicting.59 This polymorphism might con-
tribute to the plasma and tissue ACE activity and thus cause 
the disturbance of arterial wall integrity. Lacunar infarction 
was associated with this polymorphism.60 However, in the 
cases with SBI, ACE D allele showed the various results and 
there were no definite conclusive data yet.59Clinical Interventions in Aging 2010:5 submit your manuscript | www.dovepress.com
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Endothelial  nitric  oxide  synthase  (eNOS)  gene 
polymorphism and haplotypes were also suggested as a risk 
factor of SBI (mean age, 62.22 ± 11.90).61 The eNOS 894GT 
and 894GT+TT genotype showed the increased OR for SBI, 
whereas the 894GG genotype did not (OR = 2.00; 95% CI: 
1.30–3.08; OR = 2.05, 95% CI: 1.34–3.16, respectively). 
This polymorphism was also suggested as a risk factor of the 
lacunar infarction.62 The specific haplotypes, such as -786T-
4b-894G, -786T-4b-894T, and -786C-4a-894T were more 
prevalent in the SBI patients. The eNOS involves in the 
cerebral vasodilation, vascular integrity, and the inhibition 
of smooth muscle proliferation.63–65
Single-nucleotide polymorphism (SNP) of PRKCH gene 
was associated with SBI (mean age, 66.3 ± 9.9).66 Though 
exact mechanism was not known yet, 2 SNPs rs3783799 and 
rs2230500 for AA+AG vs GG, which were common in Asian 
people, showed the positive association with silent lacunar 
infarction after adjusting confounding factors (OR = 1.27; 
95% CI: 1.09–1.48).
Besides these, the 460Trp allele of the α-adducin gene 
(ADD1) showed positive association with SBI and subcortical 
WML (OR = 1.36, 95% CI: 0.98 –1.88; 1.45 vs 1.24 mL, 
P = 0.22, respectively).67
Other considerations
In addition to earlier mentioned evidences, several other factors 
need to be considered. Cerebral amyloid angiopathy (CAA) has 
also been associated with SBI in the elderly. Diffusion-weighted 
hyperintense lesions were evaluated in 78 patients with CAA 
(mean age, 78.2 ± 8.9) and 55 patients with Alzehiemer disease/
mild cognitive impairment (mean age, 81.4 ± 8.1).68 The   former 
showed 15% asymptomatic subacute cerebral infarctions 
mainly in the cortex and subcortical white matter. The results 
also revealed a higher median number of total hemorrhages in 
the former group compared with the latter despite no differences 
in the vascular risk factors (22 vs 4, P = 0.025).
Body mass index (BMI) was also correlated with the occur-
rence of SBI.33 It is easy to measure and relate with the several 
metabolic and cardiovascular diseases, so its correlation with 
SBI could be assumed. According to the presence of SBI, 
there were significant differences in the BMI level (SBI(−) 
group: 20.8 ± 3.2 kg/m2; SBI(+) group: 22.1 ± 3.2 kg/m2), 
especially in those older than 81 years (19.6 ± 2.6 kg/m2 vs 
21.2 ± 2.8 kg/m2).
There was one report that studied the relationship between 
psychiatric diseases and SBI.69 In this study, 194 adult 
patients (mean age, 48 ± 9.7 years) who were treated for 
various psychiatric diseases were included. The prevalence 
of SBI was 3.6% based on CT scanning, and the patients with 
SBI mostly had been treated for the postconcussion syndrome 
(53.3%) and depression (42.8%). However, we could not find 
any studies that were designed for the elderly.69
There were scant reports regarding the evaluation of protec-
tive factors. In one interesting study, mild alcohol consump-
tion was proven as an independent protective   factor for SBI 
(OR = 0.31; 95% CI: 0.12–0.78).13 However, this tendency was 
Table 2 Odds ratio of major risk factors for SBI in the elderly
Risk of SBI Reference
Crude OR (95% CI) Adjusted OR (95% CI)
Hypertension 2.4 (1.7∼3.3) 8
3.47 (1.71∼7.03) 13
Metabolic  
syndrome
Overall 2.74 (1.76∼4.26)12 2.18 (1.38∼3.44)12 1.68 (1.15∼2.44)40 12, 40
elevated BP 4.51 (2.53∼8.04)12 3.75 (2.05∼6.85)12 1.89 (1.23∼2.91)40
IFG 2.02 (1.29∼3.07)12 1.74 (1.08∼2.80)12 1.35 (0.96∼1.91)40
High TG 1.28 (0.77∼2.11)12 1.54 (0.91∼2.61)12 1.39 (0.89∼2.17)40
Low HDL 1.25 (0.76∼2.06)12 1.08 (0.64∼1.82)12 0.84 (0.58∼1.22)40
Large wC 0.92 (0.59∼1.45)12 0.70 (0.41∼1.18)12 1.23 (0.72∼2.09)40
elevated CRP 1.85 (1.29∼2.63) 1.50 (1.00∼2.24) 21
elevated IL-6 2.00 (1.39~2.88) 1.85 (1.24~2.78) 21
Hyperhomocysteinemia 1.24 (1.06~1.45) 49
No. of involved CA in  
coronary artery disease
2.28 (1.39~3.76) 53
BMI 0.89 (0.79~0.98) 33
Alcohol consumption 0.31 (0.12~0.78) 13
Abbreviations: SBI, silent brain infarction; OR, odds ratio; CI, confidential interval; BP, blood pressure; IFG, impaired fasting glucose; TG, triglycerides; HDL, high-density 
lipoprotein; wC, waist circumference; CRP, C-reactive protein; IL, interleukin; CA, coronary artery; BMI, body mass index.Clinical Interventions in Aging 2010:5 submit your manuscript | www.dovepress.com
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not valid in those who were older than 50 years. There were 
some explanations for this protective effect of mild to moderate 
alcohol consumption. For example, the HDL-cholesterol level, 
especially HDL-2 and HDL-3 level, could increase through 
alcohol consumption.70,71 Also, the coagulation pathway might 
be influenced by alcohol. However, the authors failed to show a 
significant difference of HDL-cholesterol or serum fibrinogen 
level in their study population.13 Also, these results need to be 
reproduced in the elderly population.
There were controversial results between SBI and another 
important habitual factor, smoking. Smoking showed positive 
correlation with the multiplicity of SBI (r2 = 0.34; P , 0.001) 
among Japanese subjects who had several vascular risk fac-
tors (mean age, 67.2 years).72 Current smokers had more 
number of silent lesions than the ex-smokers (1.9 ± 2.2 vs 
0.5 ± 0.8, P , 0.01). In another Japanese study that enrolled 
neurologically healthy adults (mean age, 60.9 ± 7.3 years), 
there was no significant associations between smoking and 
the incidence of SBI.73 In larger western population who aged 
55–70 years, there were a significant relationship between the 
exposure of tobacco and the presence of SBI.74 The OR for 
each nonsmokers who were exposed to the tobacco smoke, 
past smokers, and current smokers increased in the order 
(OR = 1.06, 1.16, and 1.88; 95% CI: 0.64–1.75, 0.74–1.83, 
and 1.13–3.13, respectively). In addition, especially in the 
patients who underwent hemodialysis, smoking habit was 
identified as an independent risk factor for SBI (r2 = 0.378; 
P , 0.0001).17 In summary, there was not a conclusive data 
about this association until now.
Clinical signficance
Clinically overt stroke
The relationship between SBI and clinically overt stroke is one 
of the main concerns for both physicians and patients. A car-
diovascular health study was conducted prospectively on 3,324 
subjects who did not have a history of stroke.5 During the 4-year 
follow-up, 28% of subjects exhibited SBIs, and there was a sig-
nificant difference in the stroke incidence between SBI(+) and 
SBI(−) groups (18.7 per 1000 person-years vs 9.5; HR = 1.5; 
95% CI: 1.1–2.1). The median age of those who underwent 
MRI were 73.0 and 77.0 years, respectively. Those who had 
multiple silent infarctions exhibited a higher adjusted relative 
risk for the further overt stroke (HR = 1.9; 95% CI: 1.2–2.8). 
In the SBI(+) group, the following were the main determinants 
for the risk of stroke: diastolic and systolic BP, common and 
internal carotid wall thickness, and the presence of AF.
With respect to the general population, another study 
recruited 933 neurologically healthy subjects who were 
aged 30–81 (mean age, 57.5 ± 9.2 years) and followed up 
for 1–7 years.2 The prevalence of SBI was 10.6%. The annual 
incidence of stroke was higher in the SBI(+) group than 
SBI(−) group (10.1% vs 0.77%). The OR for the clinical 
stroke was 10.48 (95% CI: 3.63–30.21).
The impact of SBI on cerebral hemorrhage has not been 
clearly evaluated until now. This could be examined by 
reviewing studies focused on both SBI and cerebral microb-
leeds (cMBs). The association between SBI and cMBs were 
suggested in one cross-sectional study.75 The prevalence 
of cMBs in normal healthy subjects was 5.6% (mean age, 
67.6 ± 7.8 years; range, 38–91). Among the various risk 
factors, silent lacunar infarction was a major risk factor for 
the occurrence of cMBs (OR = 5.813; 95% CI: 2.037–16.59; 
P = 0.001). As the cMBs were suggested as a risk factor 
for cerebral hemorrhage, we could assume the correlation 
between SBI and cerebral hemorrhage. However, the authors 
did not comment on this possibility.
Dementia and cognitive decline
As a subset of the Rotterdam Scan Study, a neuropsycho-
logical test and MRI were performed twice from 1995 to 
1996 and from 1999 to 2000 in 1,015 elderly who had no 
history of stroke or dementia.76 In their results, the presence 
of baseline SBI doubled the risk of subsequent dementia in a 
period averaging 3.6 years (HR = 2.26; 95% CI: 1.09–4.70) 
and was correlated with a steeper decline in global cognitive 
function. Among the silent lesions, the thalamic infarctions 
were associated with a decline in the memory performance 
and the nonthalamic infarctions in the psychomotor speed. 
When the baseline SBI(+) group was stratified according to 
the presence of additional silent infarctions, the cognitive 
decline was confined to those who had additional ones.
In another study, the subcortical ischemic vascular 
disease group, which was characterized by multiple silent 
lacunar infarctions, showed poor executive function on a 
robust neuropsychological test.22 A total of 94 healthy elderly 
subjects aged $55 years were recruited and 33% of them had 
lacunar infarctions. The executive function was inversely 
correlated with the number of subcortical lacunar infarctions. 
These findings emphasize the need for early detection and 
prevention of such lesions.
Depression
Depressive state or major depression is a risk factor and a 
consequence of SBI. There were a scant number of papers that 
mentioned the relationship between depression and SBI in a 
prospective way. However, there was evidence that suggested Clinical Interventions in Aging 2010:5 submit your manuscript | www.dovepress.com
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the contribution of SBI to the occurrence of depression.77 
Patients with presenile and senile major depression showed 
an unusually high incidence of SBI (65.9% and 93.7%, 
respectively), suggesting their contribution to the occurrence 
of organic depression. The authors insisted that .50% of pre-
senile-onset and senile-onset major   depression was   associated 
with SBI and that such patients should be   prescribed antiplate-
lets for the   prevention of overt stroke.
Aspiration pneumonia
One interesting study showed that SBI could contribute not 
only stroke or dementia but also general medical conditions 
such as pneumonia.78 A total of 269 community-dwelling 
elderly without any history of stroke were followed up for 2 
years. After CT scans, they were divided into 2 groups accord-
ing to the presence of silent ischemic lesion. The SBI(+) 
group showed 4 times higher prevalence of pneumonia than 
the SBI(−) group over a 2-year period (OR = 4.67; 95% CI: 
1.87–11.67; P , 0.01).
Similar results were reproduced in another cross-sectional 
study for the patients with Alzheimer disease.79 A total of 
121 elderly were included (mean age with SD, 78.2 ± 7.5; 
male/female ratio = 48/73). The association between the 
aspiration pneumonia and the following risk factors were 
evaluated: age, gender, severity of dementia, SBI in the basal 
ganglia, and the use of psychotropic drugs (neuroleptics and 
benzodiazepines). Aspiration pneumonia was more prevalent 
in those who had SBI and severe dementia, and the use of 
neuroleptics was also associated with aspiration pneumonia. 
In their conclusion, it has been recommended that physi-
cians should be aware of the risk of aspiration pneumonia 
in patients with severe Alzheimer disease, who had SBI in 
that basal ganglia and took neuroleptics.
Treatment and prevention
There have been no guidelines or consensus regarding 
the treatment of SBI. As their contribution to overt stroke 
and dementia becomes evident, the efforts to manage the 
underlying risk factors should be emphasized. Also, the risk 
of aspiration pneumonia needs to be considered. There is 
theoretical background for the use of statins, NSAIDs, and 
aspirin, which could reduce inflammatory activity and pre-
vent the thrombotic process.45 However, there have been no 
supporting clinical trials for these practices.
Perspectives
SBI has the clinical significance as a target organ   damage 
caused by various underlying risk factors and also as a 
  prodrome for various overt diseases such as stroke and 
dementia. With the increasing number of elderly, early 
detection and control of risk factors should be emphasized. 
A   comment in a recent article that “covert” is a more appro-
priate term than “silent” needs to be seriously considered.7
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